IS5654A - Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim - Google Patents

Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim

Info

Publication number
IS5654A
IS5654A IS5654A IS5654A IS5654A IS 5654 A IS5654 A IS 5654A IS 5654 A IS5654 A IS 5654A IS 5654 A IS5654 A IS 5654A IS 5654 A IS5654 A IS 5654A
Authority
IS
Iceland
Prior art keywords
pyridylsulfonyl
pyrazolo
pyrimidin
intermediates
compounds
Prior art date
Application number
IS5654A
Other languages
English (en)
Inventor
Michael Devries Keith
Teresa Negri Joanna
Charles Levett Philip
Shaw Wood Sandwich Albert
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9924042.6A external-priority patent/GB9924042D0/en
Priority claimed from GB0018667A external-priority patent/GB0018667D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS5654A publication Critical patent/IS5654A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IS5654A 1999-10-11 2000-10-10 Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim IS5654A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924042.6A GB9924042D0 (en) 1999-10-11 1999-10-11 Process for thr preparation of pyrazolo[4,3-D]pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
GB0018667A GB0018667D0 (en) 2000-07-28 2000-07-28 Process for the preparation of pyrazolo [4,3-d] Pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
IS5654A true IS5654A (is) 2001-04-12

Family

ID=26244761

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5654A IS5654A (is) 1999-10-11 2000-10-10 Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim

Country Status (39)

Country Link
EP (1) EP1092720B1 (is)
JP (1) JP2001114783A (is)
KR (1) KR100395718B1 (is)
CN (1) CN1292379A (is)
AR (1) AR029767A1 (is)
AT (1) ATE286899T1 (is)
AU (1) AU6543600A (is)
BG (1) BG104840A (is)
BR (1) BR0004787A (is)
CA (1) CA2322995A1 (is)
CO (1) CO5251476A1 (is)
CZ (1) CZ20003754A3 (is)
DE (1) DE60017330D1 (is)
DZ (1) DZ3096A1 (is)
EA (1) EA003145B1 (is)
EE (1) EE200000537A (is)
EG (1) EG22775A (is)
GT (1) GT200000169A (is)
HR (1) HRP20000674A2 (is)
HU (1) HUP0003979A3 (is)
ID (1) ID27539A (is)
IL (1) IL138913A0 (is)
IN (1) IN190477B (is)
IS (1) IS5654A (is)
MA (1) MA25867A1 (is)
MX (1) MXPA00009936A (is)
NO (1) NO316072B1 (is)
NZ (1) NZ507431A (is)
OA (1) OA11495A (is)
PA (1) PA8504601A1 (is)
PE (1) PE20010682A1 (is)
PL (1) PL343140A1 (is)
SG (1) SG97950A1 (is)
SK (1) SK15052000A3 (is)
SV (1) SV2002000194A (is)
TN (1) TNSN00195A1 (is)
TR (1) TR200002959A2 (is)
UY (1) UY26388A1 (is)
YU (1) YU59100A (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
US6809200B2 (en) * 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2006219373A (ja) * 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するピリジニルピラゾロピリミジノン誘導体
ES2343141T3 (es) * 2005-11-16 2010-07-23 F. Hoffmann-La Roche Ag Nuevo procedimiento para la preparacion de thoc.
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
PE20140236A1 (es) * 2011-02-23 2014-03-14 Pfizer IMIDAZO[5,1-f][1,2,4]TRIAZINAS PARA EL TRATAMIENTO DE TRASTORNOS NEUROLOGICOS
UA125630C2 (uk) * 2016-11-21 2022-05-04 Адама Аган Лтд. Спосіб одержання метоксиметилпіридиндикарбоксилату

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
CN1134442C (zh) * 1998-04-20 2004-01-14 美国辉瑞有限公司 吡唑并嘧啶酮cGMP PDE5抑制剂、其制备方法及用途及中间体
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera

Also Published As

Publication number Publication date
EP1092720A2 (en) 2001-04-18
YU59100A (sh) 2003-10-31
HRP20000674A2 (en) 2001-08-31
BR0004787A (pt) 2001-05-22
DZ3096A1 (fr) 2004-06-20
HUP0003979A3 (en) 2002-03-28
EG22775A (en) 2003-08-31
AU6543600A (en) 2001-04-12
GT200000169A (es) 2002-04-03
SV2002000194A (es) 2002-01-23
EA200000924A3 (ru) 2001-06-25
NO20005104L (no) 2001-04-17
TNSN00195A1 (fr) 2005-11-10
EP1092720B1 (en) 2005-01-12
SK15052000A3 (sk) 2003-01-09
DE60017330D1 (de) 2005-02-17
KR20010050935A (ko) 2001-06-25
CN1292379A (zh) 2001-04-25
HU0003979D0 (en) 2000-12-28
AR029767A1 (es) 2003-07-16
MA25867A1 (fr) 2003-10-01
CZ20003754A3 (cs) 2002-06-12
NO20005104D0 (no) 2000-10-10
NO316072B1 (no) 2003-12-08
IL138913A0 (en) 2001-11-25
EE200000537A (et) 2001-06-15
BG104840A (bg) 2001-10-31
NZ507431A (en) 2002-09-27
CA2322995A1 (en) 2001-04-11
IN190477B (is) 2003-08-02
PL343140A1 (en) 2001-04-23
SG97950A1 (en) 2003-08-20
EA200000924A2 (ru) 2001-04-23
CO5251476A1 (es) 2003-02-28
KR100395718B1 (ko) 2003-08-25
PE20010682A1 (es) 2001-07-04
UY26388A1 (es) 2001-05-31
PA8504601A1 (es) 2002-02-21
ID27539A (id) 2001-04-12
EA003145B1 (ru) 2003-02-27
JP2001114783A (ja) 2001-04-24
TR200002959A2 (tr) 2001-07-23
EP1092720A3 (en) 2001-09-19
ATE286899T1 (de) 2005-01-15
MXPA00009936A (es) 2002-10-23
OA11495A (en) 2004-05-05
HUP0003979A2 (hu) 2001-12-28

Similar Documents

Publication Publication Date Title
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
IS6092A (is) Aðferð til framleiðslu á amín platínu komplexum
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
IS5209A (is) Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ónum og milliefnum af því
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
IL144516A0 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO [4,3-d] PYRIMIDIN-7-ONE COMPOUNDS AND INTERMEDIATES THEREOF
IS5654A (is) Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
DK1177165T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
DK0782982T3 (da) Fremgangsmåde til fremstilling af o-chlormethyl-phenylglyoxylsyrederivater
DK1048667T3 (da) Fremgangsmåde til fremstilling af 8-cyclopentyl-6-ethyl-3-(substitueret)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacener og dertil egnede mellemprodukter
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
DK1080076T3 (da) Forbedret fremgangsmåde til fremstilling af farmaceutisk værdifulde norbenzomorphanderivater
FI991294A (fi) Nikkelirikasteen valmistusmenetelmä
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
IS6211A (is) Aðferð til framleiðslu á setnum [1,4] díazepínó [6,7,1-hi]indól-4-ónum
DK1051401T3 (da) Fremgangsmåde til fremstilling af formylimidazoler
DK0949237T3 (da) Fremgangsmåde til fremstilling af dihydrocitral